Effect of Severe Renal Failure and Haemodialysis on the Pharmacokinetics of Levosimendan and Its Metabolites

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.46, Iss.3, 2007-01, pp. : 235-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis

By Spigset Olav Hägg Staffan Stegmayr Bernd Dahlqvist Rune

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 699-703

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant

By Bergman Arthur J.

Clinical Pharmacokinetics, Vol. 44, Iss. 6, 2005-01 ,pp. : 637-647

Adis International

Access to resources Recommend Favorite

Effect of Haemodialysis on the Pharmacokinetics of Antineoplastic Drugs

By Tomita M.

Clinical Pharmacokinetics, Vol. 43, Iss. 8, 2004-01 ,pp. : 515-527

Adis International

Access to resources Recommend Favorite

Effects of Chronic Renal Failure on the Pharmacokinetics of Ruboxistaurin and its Active Metabolite 338522

By Wise Stephen

Clinical Pharmacokinetics, Vol. 45, Iss. 3, 2006-01 ,pp. : 297-303

Adis International

Access to resources Recommend Favorite

Relationship Between the Pharmacokinetics of Levosimendan and Its Effects on Cardiovascular System

Current Drug Metabolism, Vol. 10, Iss. 2, 2009-01 ,pp. : 95-103

Bentham Science Publishers

Access to resources Recommend Favorite